共 40 条
[1]
Heymsfield S.B., Wadden T.A., Mechanisms, pathophysiology, and management of obesity, N Engl J Med, 376, pp. 254-266, (2017)
[2]
Ortega F.B., Lavie C.J., Blair S.N., Obesity and cardiovascular disease, Circ Res, 118, pp. 1752-1770, (2016)
[3]
Stefan N., Haring H.U., Hu F.B., Schulze M.B., Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications, Lancet Diabetes Endocrinol, 1, pp. 152-162, (2013)
[4]
Kim J., Eisenberg D., Azagury D., Rogers A., Campos G.M., American Society for Metabolic and Bariatric Surgery position statement on long-term survival benefit after metabolic and bariatric surgery, Surg Obes Relat Dis, 12, pp. 453-459, (2016)
[5]
Schauer P.R., Kashyap S.R., Wolski K., Et al., Bariatric surgery versus intensive medical therapy in obese patients with diabetes, N Engl J Med, 366, pp. 1567-1576, (2012)
[6]
Pareek M., Schauer P.R., Kaplan L.M., Leiter L.A., Rubino F., Bhatt D.L., Metabolic surgery: weight loss, diabetes, and beyond, J Am Coll Cardiol, 71, pp. 670-687, (2018)
[7]
Taqueti V.R., Myocardial perfusion imaging in extreme obesity: leveraging modern technologies to meet a modern challenge, J Nucl Cardiol, (2017)
[8]
Motivala A.A., Rose P.A., Kim H.M., Et al., Cardiovascular risk, obesity, and myocardial blood flow in postmenopausal women, J Nucl Cardiol, 15, pp. 510-517, (2008)
[9]
Schindler T.H., Cardenas J., Prior J.O., Et al., Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function, J Am Coll Cardiol, 47, pp. 1188-1195, (2006)
[10]
Tona F., Serra R., Di Ascenzo L., Et al., Systemic inflammation is related to coronary microvascular dysfunction in obese patients without obstructive coronary disease, Nutr Metab Cardiovasc Dis, 24, pp. 447-453, (2014)